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Abstract. 
 
The carboxy-terminal domain (CTD) of the 
largest subunit of RNA polymerase II (Pol II) contains 
multiple tandem copies of the consensus heptapeptide, 
TyrSerProThrSerProSer. Concomitant with transcrip-
tion initiation the CTD is phosphorylated. Elongating 
polymerase has a hyperphosphorylated CTD, but the 
role of this modification is poorly understood. A recent 
study revealed that some hyperphosphorylated poly-
merase molecules (Pol IIo) are nonchromosomal, and 
hence transcriptionally unengaged (Bregman, D.B., L. 
 
Du, S. van der Zee, S.L. Warren. 1995. 
 
J. Cell Biol.
 
 129:
287–298). Pol IIo was concentrated in discrete splicing 
factor domains, suggesting a possible relationship be-
tween CTD phosphorylation and splicing factors, but 
no evidence beyond immunolocalization data was pro-
vided to support this idea. Here, we show that Pol IIo 
co-immunoprecipitates with members of two classes of 
splicing factors, the Sm snRNPs and non-snRNP SerArg 
(SR) family proteins. Significantly, Pol IIo’s association 
with splicing factors is maintained in the absence of 
pre-mRNA, and the polymerase need not be transcrip-
tionally engaged. We also provide definitive evidence 
that hyperphosphorylation of Pol II’s CTD is poorly 
correlated with its transcriptional activity. Using mono-
clonal antibodies (mAbs) H5 and H14, which are 
shown here to recognize phosphoepitopes on Pol II’s 
CTD, we have quantitated the level of Pol IIo at differ-
ent stages of the cell cycle. The level of Pol IIo is similar 
in interphase and mitotic cells, which are transcription-
ally active and inactive, respectively. Finally, complexes 
containing Pol IIo and splicing factors can be prepared 
from mitotic as well as interphase cells. The experi-
ments reported here establish that hyperphosphoryla-
tion of the CTD is a good indicator of polymerase’s 
association with snRNP and SR splicing factors, but 
not of its transcriptional activity. Most importantly, 
the present study suggests that splicing factors may 
associate with the polymerase via the hyperphosphory-
lated CTD.
 
T
 
he
 
 largest subunit of RNA polymerase II (Pol II
LS)
 
1
 
 is part of the catalytic core of the enzyme that
synthesizes pre-mRNAs in all eukaryotic cells (for
reviews see Young, 1991; Corden, 1993; Dahmus, 1996).
The carboxy-terminal domain (CTD) of Pol II LS is com-
prised of tandemly repeated heptapeptides with the con-
sensus sequence TyrSerProThrSerProSer (Corden et al.,
1985). The CTD of mammals, 
 
D. melanogaster
 
 and 
 
S. cere-
visiae
 
 have 52, 44, and 26 heptapeptide repeats, respec-
tively (Corden et al., 1985; Allison et al., 1985; Zehring et al.,
1988). In mammalian cells, Pol II LS exists as an unphos-
phorylated form (Pol IIa; 
 
M
 
r
 
 
 
5
 
 220 kD), or one of a vari-
ety of hyperphosphorylated forms migrating at 
 
z
 
240 kD
(collectively called “Pol IIo”) (Cadena and Dahmus, 1987;
Zhang and Corden, 1991).
The CTD harbors all known phosphorylation sites on
eukaryotic Pol II LS molecules (reviewed in Corden, 1993;
Dahmus, 1996). It has been repeatedly shown that Pol IIa
is more efficiently recruited to in vitro pre-initiation com-
plexes than Pol IIo (Lu et al., 1991; Chesnut et al., 1992),
and that elongating Pol II is hyperphosphorylated on the
CTD (Cadena and Dahmus, 1987; Payne et al., 1989; Lay-
bourn and Dahmus, 1990; Chesnut et al., 1992; Weeks et
al., 1993; O’Brien et al., 1994). CTD phosphorylation oc-
curs concomitant with the initiation of transcription (Kang
and Dahmus, 1993; Lu et al., 1991; Payne et al., 1989; Lay-
bourn and Dahmus, 1990; Chesnut et al., 1992; Weeks et al.,
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1.
 
 Abbreviations used in this paper
 
: CTD, carboxy-terminal domain of
RNA polymerase II; MIG, mitotic interchromatin granule cluster; NuMA,
nuclear mitotic apparatus protein; Pol IIa, unphosphorylated largest RNA
polymerase II subunit; Pol II LS, largest subunit of RNA polymerase II;
Pol IIo, hyperphosphorylated largest RNA polymerase II subunit; Sm sn
RNP, Smith antigen-containing small nuclear ribonucleoprotein; SR,
serine-arginine dipeptide repeat motif.
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1993). However, the bulk of evidence indicates that CTD
phosphorylation is not needed for transcription. In the
presence of CTD kinase inhibitors RNA polymerase II
can synthesize RNA in vitro (Serizawa et al., 1993). In
fact, Pol II molecules lacking a CTD can transcribe certain
genes in vitro (Kim and Dahmus, 1989; Buratowski and
Sharp, 1990; Zehring and Greenleaf, 1990). Although
transcription from certain promoters requires a TFIIH-
associated CTD kinase (Akoulitchev et al., 1995), an abso-
lute requirement for CTD phosphorylation has yet to be
demonstrated, since this kinase may phosphorylate tran-
scriptional proteins besides Pol II’s CTD. Indeed, basal
and activated in vitro transcription were clearly shown to
take place without CTD phosphorylation in another sys-
tem (Mäkela et al., 1995). Therefore, despite the repeated
observation that the CTD becomes phosphorylated as the
polymerase begins to transcribe, it remains unclear whether
CTD phosphorylation regulates Pol II’s transcription cy-
cle, or whether this modification merely coincides with the
initiation of transcription.
Several putative CTD-binding proteins have been re-
ported. Usheva and colleagues reported that Pol IIa, but
not Pol IIo, interacts directly with TATA-binding protein
(TBP), a key subunit of TFIID (Usheva et al., 1992). This
finding, together with the timing of CTD phosphorylation,
is consistent with the “promoter clearance” hypothesis,
whereby phosphorylation of the CTD releases the poly-
merase from the promoter (discussed in Dahmus, 1996).
In addition, cross-linking studies indicate that unphospho-
rylated CTD peptides directly interact with other tran-
scription factors, viz., subunits of TFIIE and TFIIF (Kang
and Dahmus, 1996). The CTD has also been shown to as-
sociate with a “mediator” complex containing multiple basal
transcription factors and suppressers of RNA polymerase
B (SRB) proteins (Thompson et al., 1993; Kim et al., 1994;
Koleske and Young, 1994; for review see Koleske and
Young, 1995). Pre-assembled “holoenzymes” containing
an unphosphorylated CTD can be recruited to preinitia-
tion complexes. The “mediator” promotes phosphoryla-
tion of the CTD via TFIIH-associated kinase(s), and it
bestows upon polymerase the ability to respond to trans-
activator proteins in vitro. Thus, in agreement with the
promoter clearance model of CTD function, transactivat-
ing proteins may stimulate the mediator to activate CTD
phosphorylation coincident with transcriptional initiation.
The mediator protein(s) that directly bind to the unphos-
phorylated CTD have yet to be identified. In addition, at
least one other CTD kinase, apparently not part of the me-
diator, has been shown to be required for normal CTD
phosphorylation in vivo (Sterner et al., 1995; Lee and
Greenleaf, 1991). Finally, Yuryev and colleagues used a
yeast two-hybrid screen to identify CTD interacting pro-
teins in rat cells (Yuryev et al., 1996). Four proteins were
identified, each containing repetitive SerArg dipeptide
(SR) motifs characteristic of the SR superfamily of pro-
teins. Among the putative CTD-binding proteins reported
to date, rA1 is the only one that interacts with Pol II mole-
cules containing a hyperphosphorylated CTD.
Many studies indicate a close correlation between CTD
phosphorylation and the initiation of transcription, but lit-
tle is known about the phosphorylation state or fate of
Pol II molecules that have disengaged from the chromatin.
Recently, a substantial fraction of Pol IIo was shown to be
concentrated in discrete nuclear domains that overlap with
20–50 “speckle” domains, which are enriched with splicing
factors (Bregman et al., 1994, 1995). Studies from other
labs indicated that the bulk of Pol II transcription takes
place in the nucleoplasm outside of these domains (Wan-
sink et al., 1993; Jackson et al., 1993), so it was proposed
that much of the Pol IIo in these domains is probably not
engaged in transcription (Bregman et al., 1995). Since that
time, a handful of specific Pol II transcripts have been lo-
calized to the periphery of the speckle domains, and some
transcripts (e.g., collagen I
 
a
 
1) overlap extensively with the
speckle domains. Thus, the precise spatial relationship be-
tween Pol II transcription and the speckle domains re-
mains poorly understood, and the interested reader is re-
ferred to several recent reviews of this topic (Fakan, 1994;
Wansink et al., 1994; Bazett-Jones, 1995; Moen et al., 1995;
Spector et al., 1995; van Driel et al., 1995). Nevertheless,
our finding that transcriptional inhibitors and heat shock
induce multiple SR proteins, Sm snRNPs, and Pol IIo to
synchronously reorganize into enlarged, round speckles,
suggests that some Pol IIo molecules in these domains are
not engaged in transcription. A similar, but more striking
reorganization takes place at the onset of mitosis when
transcription abruptly ceases: Pol IIo, multiple SR proteins
and Sm snRNPs become sequestered in mitotic interchro-
matin granule clusters (MIGs), dot-like regions (
 
z
 
0.1 
 
m
 
m
– 
 
z
 
1 
 
m
 
m in diameter) scattered throughout the dividing
cell, far removed from the condensed chromatin (Warren
et al., 1992; Bregman et al., 1994).
Our previous immunolocalization studies indicated that
splicing factors and transcriptionally unengaged Pol IIo
molecules are sequestered in the same discrete nonchro-
mosomal compartment when transcription diminishes or
ceases (Bregman et al., 1995). Here, we show that Pol IIo
co-immunoprecipitates with splicing factors of the Sm sn-
RNP and non-snRNP SerArg (RS) families. We also re-
port two novel and intriguing findings. First, splicing fac-
tors are tightly associated with Pol IIo in the absence of
pre-mRNA; and second, the hyperphosphorylated poly-
merase need not be transcriptionally engaged to associate
with splicing factors. Perhaps the most important implica-
tion of these findings is that the splicing factors associate
with polymerase via the phosphorylated CTD. In agree-
ment with the above findings, we also provide definitive
evidence that hyperphosphorylation of the CTD corre-
lates poorly with Pol II’s transcriptional activity in vivo. In
summary, we have established for the first time that CTD
phosphorylation is a better indicator of Pol II’s association
with Sm snRNPs and SR proteins than its transcriptional
activity. The outcome of the experiments described here
prompted us to ask whether a functional relationship ex-
ists between Pol II’s CTD and pre-mRNA splicing, an idea
explored in an accompanying paper (Du and Warren,
1997).
 
Materials and Methods
 
Antibodies 
 
Anti-Pol II LS mAbs (H5, H14 and 8WG16) and control IgM (mAb H22)
are described elsewhere (Bregman et al., 1995; Thompson et al., 1989). 
Kim et al. 
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Anti-RPII is a rabbit polyclonal antibody directed at Pol II LS (Kim and
Dahmus, 1986). Anti-NuMa is a polyclonal rabbit antibody directed at the
236-kD nuclear mitotic apparatus protein (Yang et al., 1992). The follow-
ing mAbs are directed towards Sm antigens and SR family proteins: mAb
Y12 (Lerner et al., 1981; Pinto and Steitz, 1989) recognizes the Sm snRNP
B/B
 
9
 
 and D, as well as a 70-kD proteolytic fragment of intron-binding pro-
tein (IBP). mAb 7.13 specifically recognizes Sm snRNP protein D (Bloom
et al., 1993). mAb 104 (Roth et al., 1990) and mAb 3C5 (Turner and Fran-
chi, 1987) are IgMs that recognize several members of the SR family. mAb
SC35 is an IgG directed against spliceosome assembly factor, a 35-kD SR
family protein (Fu and Maniatis, 1990). mAb B4A11 is a mouse IgM that
intensely stains nuclear speckle domains (Blencowe et al., 1994), and mAb
3A7/64 is a mouse IgG directed at the 64-kD subunit of the cleavage stim-
ulation factor (CstF) involved in 3
 
9
 
 polyadenylation and processing of pre-
mRNAs (Takagaki et al., 1990). mAb M2 (Kodak) binds to the Flag
 
R
 
 pep-
tide, AspTyrLysAspAspAspAspLys.
 
Cell Culture, Immunofluorescence Microscopy, and 
Image Analysis 
 
Cells were maintained as described (Bregman et al., 1994). Immunostain-
ing was performed as described (Bregman et al., 1994). To visualize mi-
totic chromosomes, cells were stained with 4
 
9
 
, 6-diamidino-2-phenylindole
(DAPI) as described (Warren et al., 1992). Images were captured using
a Photometrics CH250 CCD camera (CE200A/LC200 liquid cooling),
mounted on an Axioskop (Zeiss). Image analysis software included NIH-
Image
 
R
 
, Registration v1.1d2
 
R
 
, and Adobe Photoshop 2.0
 
R
 
.
 
CTD Peptide Expression Plasmids and
Transient Transfection 
 
Complete descriptions of pF-CTD52 and pF-CTDless are given in the ac-
companying manuscript (Du and Warren, 1997). pF-CTD52 expresses a
fusion protein comprised of an NH
 
2
 
-terminal Flag peptide
 
R
 
 epitope (Asp-
TyrLysAspAspAspAspLys) attached to 636 amino acids derived from the
COOH terminus of human Pol II LS, whereas “pF-CTDless” expresses a
“non-CTD” segment of Pol II LS (residues 1335 to 1570) that is Flag-
tagged in the NH
 
2
 
 terminus. Cells were transfected using Lipofectin
 
R
 
(GIBCO BRL, Gaithersburg, MD), according to the manufacturer’s in-
structions.
 
Cyanogen Bromide Digestion
 
Pol II was cyanogen bromide (CNBr) digested as described (Cadena and
Dahmus, 1987).
 
Centrifugal Elutriation, Preparation of
Nocodazole-arrested Mitotic Cells and Flow
Cytometric Cell Cycle Analysis
 
Performed as described (Bregman et al., 1994; Tobey et al., 1967). No-
codazole-arrested, mechanically detached mitotic cells were judged to be
99% pure by counting 
 
z
 
200 DAPI-stained mitotic figures under the fluo-
rescence microscope.
 
Nuclear Extracts, Immunoprecipitation,
and Immunoblotting
 
HeLa cell nuclei (Dignam et al., 1983) were extracted with ice-cold 50 mM
Tris-HCl, 250 mM NaCl, 1% Triton X-100, 1 mM PMSF, 0.2 mM NaVO
 
4
 
,
5 mM 
 
b
 
-glycerophosphate, pH 7.4 (T buffer). Insoluble material was cen-
trifuged for 10 min at 15,000 
 
g
 
, and the supernatant was used for immuno-
precipitation. Nuclear extracts were incubated with 50 
 
m
 
l of staphylococ-
cal protein G coupled–agarose beads, precharged with an excess of
antibody. After incubation for 4 h at 4
 
8
 
C, the beads were washed three
times with ice cold T buffer, boiled in SDS sample buffer and subjected to
SDS-PAGE and immunoblotting. Immunoblotting was performed as de-
scribed (Bregman et al., 1995).
 
Metabolic Labeling with [
 
32
 
P]Orthophosphate, 
Immunoprecipitation, RNase A Digestion, and Analysis 
of RNAs
 
HeLa cells were grown for 24 h in phosphate-free RPMI 1640 containing
10% dialyzed FBS, 1% undialyzed FBS, and [
 
32
 
P]orthophosphate (0.5
mCi/ml). Cells were washed three times in ice-cold PBS, lysed in T Buffer
(see above), and centrifuged to remove insoluble material. The superna-
tant was used for immunoprecipitations as described above. To determine
the content of 
 
32
 
P-labeled RNA in the complexes, immunoprecipitates
were incubated with or without RNase A (5 
 
m
 
g/ml), phenol extracted, eth-
anol precipitated, rehydrated in loading buffer, and resolved on a 5% or
10% polyacrylamide/urea gel as described (Sambrook et al., 1989). The
gels were dried and processed for autoradiography.
 
Results
 
mAbs H5 and H14 Bind to Different Phosphoepitopes 
on Pol II’s CTD
 
In a previous study we showed that pretreatment of Pol II
LS with alkaline phosphatase abolishes binding of mAbs
H5 and H14 (Bregman et al., 1995), suggesting that these
mAbs may recognize phosphoepitopes on the CTD (Ca-
dena and Dahmus, 1987; Zhang and Corden, 1991). How-
ever, we had no direct evidence to support this idea. Here,
we ask whether mAbs H5 and H14 bind to recombinant
human CTD-derived proteins expressed in HeLa cells
(Materials and Methods). Interestingly, the recombinant
CTD proteins lack a conventional nuclear localization sig-
nal, but they still accumulate in the nucleus (see Du and
Warren, 1997). Furthermore, CTD proteins are apparently
phosphorylated in vivo by endogenous protein kinase(s)
to yield two species, “CTDa” and “CTDo” (Fig. 1 
 
A
 
).
Both antibodies recognize the full-length CTD (52 re-
peats) (Fig. 1 
 
A
 
). Note that both mAbs bind strongly to
CTDo, whereas only mAb H14 blots strongly to CTDa
(Fig. 1 
 
A
 
). Finally, in vitro pre-incubation of these CTDs
with alkaline phosphatase abolishes binding by either
mAb (data not shown).
Next, we asked whether mAbs H5 and H14 also bind to
CTD epitopes on native Pol IIo molecules. Pol II was
immunoprecipitated from HeLa cells with mAb H14 and
digested with CNBr to prepare intact CTD fragments
(Cadena and Dahmus, 1987). The immunoprecipitated,
CNBr-digested Pol II molecules were subjected to SDS-
PAGE and blotted with two antibodies known to recog-
nize the CTD: mAb 8WG16 (Thompson et al., 1989) and
anti-RPII (Kim and Dahmus, 1986) (Fig. 1 
 
B
 
, lanes 
 
2
 
 and 
 
4
 
,
respectively; CTD fragment is indicated by a bracket). mAb
H14 also recognizes the chemically excised CTD peptide
(Fig. 1 
 
B
 
, lane 
 
6
 
, 
 
bracket
 
). However, the H5 phospho-
epitope is destroyed during the CNBr procedure (Fig. 1 
 
B
 
,
lane 
 
8
 
). Taken together, the above results indicate that
mAbs H5 and H14 recognize distinct phosphoepitopes in
Pol II’s CTD.
It is well established that the CTD is phosphorylated
concomitant with the initiation of transcription (see Intro-
duction). In a study to be reported elsewhere, we have
used an in situ photoaffinity labeling technique (Bartho-
lomew et al., 1986) to show that mAbs H5 and H14 recog-
nize a population of elongating Pol IIo molecules (Zeng
et al., 1997). Indeed, multiple species of Pol II LS, which
are differentially phosphorylated on the CTD, are tran-
scriptionally active under the conditions of the nuclear
run-on assay (Zeng et al., 1997). These findings are in
agreement with previous transcription studies performed
in vitro (Kang and Dahmus, 1993; Lu et al., 1991; Payne et 
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al., 1989; Laybourn and Dahmus, 1990; Chesnut et al.,
1992) and in vivo (O’Brien et al., 1994; Weeks et al., 1993).
 
The Steady-state Level of CTD Phosphorylation Is 
Relatively Constant during the Cell Cycle
 
The overall level of Pol II transcription fluctuates widely
during the cell cycle (Taylor, 1960; Prescott and Bender,
1962; Shermoen and O’Farrell, 1991). An abrupt cessation
of transcription takes place at the onset of mitosis (Sher-
moen and O’Farrell, 1991; Ferreira et al., 1994), and abun-
dant nonchromosomal Pol II is present during mitosis
(Warren et al., 1992; Bregman et al., 1994). Pol II tran-
scription resumes during late telophase and continues un-
til G
 
2
 
/M (Ferreira et al., 1994). To better understand the
functional significance of CTD phosphorylation, we asked
whether the level of Pol IIo fluctuates in parallel with
marked changes in transcriptional activity that takes place
during the cell cycle (Fig. 2). HeLa cells were separated by
centrifugal elutriation into 
 
z
 
10 fractions, which were ana-
lyzed by flow cytometry. Four representative cell cycle–
enriched fractions are presented in Fig. 2, 
 
A–D.
 
 An equal
number of cells from each fraction was solubilized in SDS
sample buffer, subjected to SDS-PAGE and immunoblot-
ted with mAb H14 or mAb H5 (Fig. 2, 
 
A
 
9
 
–
 
D
 
9
 
, 
 
bottom pan-
els
 
). Quantitative scanning of these blots reveals less than
a twofold fluctuation in the level of Pol IIo as determined
by blotting with mAb H14, and less than a 5% fluctuation
with mAb H5. Significantly, the G2/M-enriched cells have
an overall level of Pol IIo that is very similar to the G1 en-
riched cells (Fig. 2, compare 
 
B
 
9
 
 and 
 
D
 
9
 
). Similar results
have been obtained using pharmacologically synchronized
G1, S, and M phase cell populations (Kim, E., L. Du, D.B.
Bregman, and S.L. Warren, unpublished results). We con-
clude that phosphorylation of the CTD does not correlate
well with Pol II’s transcriptional activity.
 
Pol IIo Is Associated with Sm snRNPs and SR Proteins 
In Vivo 
 
Our previous observations that Pol IIo and multiple splic-
ing factors are colocalized in nuclear domains (Bregman
et al., 1994, 1995) prompted us to ask whether Pol IIo can
be co-immunoprecipitated with splicing factors. Antibod-
ies that bind to a variety of snRNPs and SR family pro-
teins were used to immunoprecipitate complexes from
HeLa cell nuclear extracts under nondenaturing condi-
tions (Fig. 3). First, the presence of SR proteins and Sm sn-
RNPs in the complexes was confirmed by immunoblotting;
mAb Y12 immunoprecipitates the B/B
 
9
 
 Sm snRNPs, a
Figure 1. mAbs H5 and H14 bind to the CTD of RNA polymerase II. (A) mAbs H5 and H14 recognize recombinant CTD proteins ex-
pressed in HeLa cells. HeLa cells were transfected with pF-CTDless or pF-CTD52 (see Materials and Methods). 24 h later, the cells
were solubilized with SDS sample buffer, subjected to 7% SDS-PAGE, and immunoblotted with mAb H5 or mAb H14. (B) mAb H14
binds to CTD of native RNA polymerase II. Pol II LS was immunoprecipitated with mAb H14 and digested with CNBr (Cadena and
Dahmus, 1987). CNBr digested material was solubilized in SDS sample buffer, subjected to 7% SDS-PAGE, and immunoblotted with
mAb 8WG16, RPII (polyclonal rabbit anti-Pol II; Kim and Dahmus, 1986), mAb H14, mAb H5, and mAb H22 (control IgM). IB, im-
munoblotting antibody. Ig, mouse immunoglobulin chains; R, rabbit immunoglobulin chains. CNBr, cyanogen bromide. CNBr-released
CTD indicated by brackets on the right hand side of gels. Pol IIo, hyperphosphorylated largest subunit of Pol II. Numbers at margins of
panels indicate apparent molecular weights in kilodaltons.
Figure 2. Overall CTD phosphorylation remains relatively con-
stant during the cell cycle. S3 HeLa cells were separated by cen-
trifugal elutriation as described (Bregman et al., 1994), and 10
fractions were analyzed by flow cytometry. An equal number of
cells from each fraction was boiled in SDS sample buffer, electro-
phoresed, and blotted with mAb H14 or H5. Four representative
fractions, each enriched for a different stage of the cell cycle, are
presented in A–D (top). Lower panels A9–D9 correspond to up-
per panels A–D. IIo, hyperphosphorylated largest subunit of
RNA polymerase II. Numbers at margins of panels indicate ap-
parent molecular weights in kilodaltons. 
Kim et al. 
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z
 
70-kD proteolytic fragment of the intron-binding pro-
tein (Pinto and Steitz, 1989), and several SR family pro-
teins recognized by mAb 104 (data not shown). In addi-
tion, complexes prepared with mAbs 104 and 3C5 contain
multiple SR family proteins as shown previously (Roth et al.,
1991; Turner and Franchi, 1987; Blencowe et al., 1995;
data not shown). To ascertain whether these previously re-
ported immunoprecipitates also contain Pol IIo, additional
samples were electrophoresed and immunoblotted with
mAb H14 (Fig. 3, lanes 
 
4–7
 
). The results demonstrate that
Pol IIo is co-immunoprecipitated with two mAbs directed
at SR family proteins (Fig. 3, lanes 
 
4
 
 and 
 
5
 
). Pol IIo is also
co-immunoprecipitated with mAb 7.13, which binds to the
Sm snRNP D (Bloom et al., 1993) (Fig. 3, lane 
 
7
 
), and
mAb Y12, which binds to Sm snRNPs B and B
 
9
 
 (Fig. 3,
lane 
 
6
 
). We have compared the amount of Pol IIo immu-
noprecipitated by an excess of the following mAbs: 104,
3C5, Y12, 7.13, and H14. Quantitative scanning of three
immunoblots similar to Fig. 3 indicates that the anti-Sm
snRNP and anti-SR antibodies immunoprecipitate 5–20%
as much Pol IIo from nuclear extracts as does anti-Pol IIo
mAb H14 (Kim, E., L. Du, D.B. Bregman, and S.L. War-
ren, unpublished results).
Several control immunoprecipitations were performed
to determine whether or not other nuclear proteins are
present in these complexes (Fig. 3, lanes 
 
10–21
 
). One con-
trol is the nuclear mitotic apparatus protein (NuMA), a
236-kD protein, which has been reported to exist in a dif-
fuse nucleoplasmic distribution (Yang et al., 1992; Comp-
ton et al., 1992) and in nuclear speckle domains during in-
terphase (Zeng et al., 1994). NuMa is abundant in whole
nuclear extracts (Fig. 3, lane 
 
10
 
), but it is not detected in
immunoprecipitates prepared with mAbs 104, Y12, or H14
(Fig. 3, lanes 
 
11–13
 
). Another control, mAb B4A11, rec-
ognizes a 
 
z
 
300-kD nuclear matrix antigen and intensely
stains speckle domains (Blencowe et al., 1994). Neither the
 
z
 
300-kD protein, or the other proteins recognized by
mAb B4A11 were found to co-immunoprecipitate with
mAbs 104, Y12, or H14 (Fig. 3, lanes 
 
14–17
 
). A third con-
trol, mAb 3A7/64, recognizes the 64-kD subunit of cleav-
age stimulation factor (CstF), which participates in the
processing of 3
 
9
 
 ends of pre-mRNAs (Takagaki et al.,
1990). The p64 protein is readily detected in nuclear ex-
tracts, but not in immunoprecipitates prepared with mAbs
104, Y12, or H14 (Fig. 3, lanes 
 
19–21
 
). Finally, anti-
NuMA, mAb B4A11, mAb 3A7/64, and several additional
control mAbs directed at nuclear proteins failed to co-immu-
noprecipitate Pol IIo (Kim, E., L. Du, D.B. Bregman, and
S.L. Warren, unpublished results). The above controls
clearly show the specificity of Pol IIo’s association with the
splicing factors (Fig. 3, lanes 
 
4–7
 
).
Repeated attempts to co-immunoprecipitate Sm snRNPs
and SR proteins with mAbs H5 and H14 failed. In fact, in
the presence of mAb H5 or mAb H14 (IgMs), Pol IIo is
not co-immunoprecipitated with mAb Y12 (IgG) implying
that these CTD-specific mAbs cause Pol IIo to be released
from the complexes (unpublished results). In an attempt
to co-immunoprecipitate SR proteins with a different anti-
body directed at Pol II, we chose mAb 8WG16. In contrast
to mAbs H5 and H14, which are multivalent IgMs directed
at phosphoepitopes on the CTD, mAb 8WG16 is a biva-
lent IgG directed against unphosphorylated epitope(s) on
the CTD. To interpret such an experiment, it is essential to
remember that even “hyperphosphorylated” Pol II mole-
cules (i.e., Pol IIo species) contain many unphosphor-
ylated serine and threonine residues on the CTD (Zhang
and Corden, 1991). Thus, although mAb 8WG16 immuno-
precipitates and blots predominantly hypophosphorylated
Pol IIa molecules (
 
z
 
220 kD), it also immunoprecipitates
and blots Pol IIo molecules (240 kD), albeit weakly (see
Figure 3. The largest subunit of RNA polymerase II is associated with SR family proteins and Sm snRNPs. HeLa cell nuclear extracts were
used for immunoprecipitations as described in the Materials and Methods. Immunoprecipitations with mAbs Y12 (anti-Sm), H5 (anti-
Pol II CTD), H14 (anti-Pol II CTD), H22 (control IgM), 104 (anti-SR family proteins), and 3C5 (anti-SR family proteins), 7.13 (anti-
Sm) and M2 (control IgG) were washed, boiled in SDS sample buffer, electrophoresed, and immunoblotted with mAb H14 (lanes 1–9),
anti-NuMA (lanes 10–13), mAb B4A11 (lanes 14–17), mAb 3A7/64 (lanes 18–21), or mAb 104 (lanes 14–16). Blocks at left of lane 14,
proteins recognized by nuclear matrix antibody B4A11. Blocks at right margin of lane 24, mAb 104-reactive SR proteins. Ig, mouse im-
munoglobulin m chains, present only in samples immunoprecipitated with IgM antibodies; R, rabbit anti-mouse immunoglobulin added
to immunoprecipitates and detected only in anti-NuMA blot. IIo, hyperphosphorylated form(s) of the largest subunit of RNA poly-
merase II. p64, cleavage stimulation factor (64 kD subunit). NuMA, nuclear mitotic apparatus protein, 236 kD. Numbers at margins of
panels indicate apparent molecular weights in kilodaltons. 
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Bregman et al., 1995). In contrast to mAbs H5 and H14,
mAb 8WG16 co-immunoprecipitates several mAb 104-reac-
tive SR proteins (Fig. 3, lane 23). 
Anti-SR Specific mAb 104 Preferentially
Co-immunoprecipitates Pol IIo
Next, we asked whether the Pol II LS molecules that are
associated with SR proteins have a hyperphosphorylated
or hypophosphorylated CTD (Fig. 4). To answer this ques-
tion, we have again taken advantage of mAbs H5, H14,
and 8WG16, which recognized different phosphorylated
forms of Pol II LS (Bregman et al., 1995). mAb H5 binds
specifically to a subset of Pol IIo molecules, which migrate
at z240 kD (Bregman et al., 1995), whereas mAb H14 rec-
ognizes various phosphorylated forms that migrate be-
tween 220 and 240 kD (Bregman et al., 1995). mAb
8WG16 binds to unphosphorylated CTD epitopes (Thomp-
son et al., 1989; Bregman et al., 1995), so it preferentially
binds to Pol IIa (z220 kD). Recall that although mAb
8WG16 can recognize Pol IIo, mAbs H5 and H14 are
much more sensitive probes for Pol IIo.
HeLa cell nuclear extracts were incubated with mAb
8WG16, mAb 104, mAb H22 (IgM control), or mAb M2
(IgG control). Immune complexes were captured on aga-
rose beads, washed, boiled in SDS sample buffer, electro-
phoresed, and immunoblotted with mAb 8WG16, mAb
H14, or mAb H5 (Fig. 4). The results show that mAb 104
co-immunoprecipitates Pol IIo (Fig. 4, lanes 8 and 13). Immu-
noblotting with mAb 8WG16 reveals only background lev-
els of Pol IIa in the complexes (Fig. 4, compare lane 3 to
lanes 4 and 5). The Pol IIo molecules which are co-immu-
noprecipitated with mAb 104 can be easily detected by
mAbs H5 and H14, but mAb 8WG16 does not detect this
subset of Pol IIo. The amount of Pol IIo in these com-
plexes may be insufficient to be detected by mAb 8WG16.
Alternatively, mAb 104 may co-immunoprecipitate a sub-
set of Pol IIo molecules that has few unphosphorylated
serine and threonine residues in the CTD.
Pol IIo’s Association with Sm snRNPs and Certain SR 
Proteins Resists Exhaustive RNase Digestion
One possible explanation for the above results is that the
Pol IIo/SR protein/Sm snRNP “complexes” are transcrip-
tionally engaged Pol IIo molecules connected to snRNPs
and SR proteins via partially transcribed pre-mRNAs. If
this is true, then RNase digestion should release Pol IIo
from the immunoprecipitated complexes. To test this idea,
we first analyzed the RNA content in the immunoprecipi-
tated material (Fig. 5 A). HeLa cells were metabolically la-
beled with [32P]orthophosphate, washed in PBS and ex-
tracted with T buffer (see Materials and Methods). The
supernatant was used for immunoprecipitation with mAb
Y12 (directed at Sm snRNPs) and mAb 104 (directed at
SR family proteins), under nondenaturing conditions as in
Figs. 3 and 4.
The results show that mAb Y12 co-immunoprecipitates
multiple RNA species, including hnRNA and Sm snRNAs,
whereas mAb 104 co-immunoprecipitates predominantly
hnRNA (Fig. 5 A, lanes 2 and 5, respectively). Signifi-
cantly, all 32P-labeled RNA species are destroyed by incu-
bating the immunoprecipitated complexes with RNAase
A (Fig. 5 A, lanes 3 and 6, respectively). Despite the ex-
haustive RNase A treatment, the amount of Pol IIo which
co-immunoprecipitate with the SR proteins is not dimin-
ished significantly (Fig. 5 B, compare lanes 2 and 8).
RNAase treatment reduced the amount of Pol IIo co-immu-
noprecipitating with Sm snRNPs in some experiments
(Fig. 5 B, compare lanes 4 and 10), while minimal changes
were detected in other experiments (Fig. 5 B, compare
lanes  12 and 13).
A Hyperphosphorylated Form of Pol II LS
Is Associated with Sm snRNPs and SR Family Proteins 
during Mitosis
The above results argue that Pol IIo’s association with
mAb 104 reactive SR proteins and Sm snRNPs may not be
Figure 4. Anti-SR specific mAb 104 preferentially co-immunoprecipitates Pol IIo. Nuclear extracts and immunoprecipitations were pre-
pared as in Fig. 3. Immunoprecipitations were performed using mAbs indicated at the top of the panels and immunoblotting with mAbs
at the bottom. Extract, HeLa cell nuclear extract. Ig, mouse immunoglobulin chains; IIo, hyperphosphorylated largest subunit of RNA
polymerase II. IIa, hypophosphorylated largest subunit of RNA polymerase II. Numbers at margins of panels indicate apparent molec-
ular weights in kilodaltons. Asterisks indicate mAb 8WG16 cross-reactive proteins at z100 kD and z85 kD.Kim et al. RNA Polymerase II and Splicing Factors 25
dependent on pre-mRNA. To further explore this idea,
we have taken advantage of mitotic cells, which do not
synthesize RNA (Taylor, 1960; Prescott and Bender, 1962;
Ferreira et al., 1994). In addition, nascent Pol II transcripts
are aborted during mitosis (Shermoen and O’Farrell,
1991) and Pol II accumulates in nonchromosomal MIGs
(Warren et al., 1992; Bregman et al., 1994). First, we com-
pared the subcellular distributions of condensed mitotic
chromosomes, Pol IIo and SC35 (a representative SR fam-
ily splicing protein in MIGs) using imaging techniques
that are superior to our earlier studies (Fig. 6, A–D).
Prometaphase chromosomes are clearly visible as indi-
cated by blue pseudocolor (Fig. 6 C). As shown by red
pseudocolor in Fig. 6 A, SC35 is distributed exclusively in
nonchromosomal dot-like MIGs, shown previously to har-
bor SR family proteins and Sm snRNPs (Spector et al.,
1991; Ferreira et al., 1994). The distribution of mAb H5 re-
active Pol IIo is more complex (Fig. 6 B, green pseudo-
color). Note that SC35 and Pol IIo are precisely colocal-
ized in the dot-like MIGs as indicated in the merged image
(Fig. 6 D, yellow). This population of Pol IIo molecules is
not associated with chromosomes. Another population of
Pol IIo is distributed in a perichromosomal pattern (Fig. 6,
B and D). Neither population of the polymerase can be
transcriptionally engaged at this stage of the cell cycle, but
all of the Pol II visualized in Fig. 6 is hyperphosphorylated
on the CTD (mAb H5 recognizes only Pol IIo). Signifi-
cantly, there is a striking colocalization of SC35 and Pol
IIo in the MIGs. 
The above results prompted us to ask whether Pol IIo
can be co-immunoprecipitated with SR proteins and Sm
snRNPs from mitotic cells. Thus, we prepared 99% pure
mitotic HeLa cell extracts (Materials and Methods), which
were used for immunoprecipitation with mAbs Y12, 3C5,
104, M2 (control IgG), and H22 (control IgM). The immu-
noprecipitates were washed extensively, boiled in SDS
sample buffer, subjected to SDS-PAGE, and blotted with
mAb H14 (Fig. 6 E). The results show that Pol IIo can be
co-immunoprecipitated with Sm snRNPs and SR proteins
during mitosis (Fig. 6, lanes 1, 4, and 5). Similar results
were obtained by blotting with mAb H5 (data not shown).
Note that in pure mitotic cell extracts Pol IIo migrates as a
thin z240-kD band (Fig. 6 E, lane 6), in agreement with
the results obtained with G2/M-enriched cells prepared by
elutriation (Fig. 2 D9). These experiments, together with
previous studies, indicate that “megacomplexes” com-
prised of SR family proteins, Sm snRNPs, and hyperphos-
phorylated Pol II molecules are sequestered in discrete
nonchromosomal domains (i.e., MIGs in mitotic cells and
speckle domains in the interphase nucleus).
Discussion
In the present study, we first established that mAbs H5
Figure 5. Pol IIo’s association with SR proteins and Sm snRNPs resists RNase digestion. HeLa cells were grown overnight in low phos-
phate medium supplemented with [32P]orthophosphate (0.5 mCi/ml). The cells were extracted for immunoprecipitation as in Figs. 3 and
4. Immunoprecipitating antibodies include Y12 (anti-Sm snRNP), 104 (anti-SR family proteins), H14 (anti-Pol II), M2 (control IgG),
and H22 (control IgM). Immunoprecipitates were washed extensively, and then incubated with RNase (1) or without RNase (2) as de-
scribed in Materials and Methods. (A) RNA content of immunoprecipitates before and after RNase treatment. Immunoprecipitates
prepared from 32P-labeled cells were phenol extracted, ethanol precipitated, rehydrated in loading buffer, and resolved on a 5% (left
panel) or 10% (right panel) polyacrylamide/urea gel. The gels were dried and processed for autoradiography. hnRNA, heterogeneous
RNAs. U1, U2, U4, U5, and U6, U-rich Sm snRNAs. tRNA, transfer RNA. (B) Proteins in immunoprecipitates before and after RNase
treatment. Immunoprecipitates prepared under nonradioactive, but otherwise identical conditions, to those in A. After the RNase di-
gestion step, samples were boiled in SDS sample buffer, subjected to 7% SDS-PAGE electrophoresis, transferred to nitrocellulose, and
immunoblotted with anti-Pol II mAb H14. Ig, mouse immunoglobulin chains; IIo, hyperphosphorylated Pol II. Numbers at margins of
panels indicate apparent molecular weights in kilodaltons.The Journal of Cell Biology, Volume 136, 1996 26
and H14 bind to phosphoepitopes on Pol II’s CTD (see
Fig. 1). As expected from previous studies, these phospho-
epitopes are present on transcriptionally engaged poly-
merase molecules (Zeng et al., 1997). But hyperphosphor-
ylation of the CTD does not necessarily indicate that Pol
II is transcriptionally engaged, since interphase cells and
transcriptionally inactive mitotic cells have similar levels
of Pol IIo (see Fig. 2). Taken together with the immunolo-
calization results on mitotic (Fig. 6) and interphase cells
(Bregman et al., 1995), these data indicate that one frac-
tion of Pol IIo molecules is transcriptionally engaged,
while another fraction is not. The latter conclusion is fur-
ther supported by recent immunolocalization studies using
Triton X-100–permeabilized, transcriptionally active cells
in which the majority of nascent, BrU-labeled transcripts
are located in the nucleoplasm outside (or at the periph-
ery) of the large Pol IIo-rich domains (Zeng et al., 1997).
Thus, hyperphosphorylation of the CTD is poorly corre-
lated with transcriptional activity, even though CTD phos-
phorylation takes place at the time when polymerase ini-
tiates transcription.
The discrete Pol IIo-rich domains are highly enriched
with splicing factors (Bregman et al., 1995). These mor-
phological observations led us to ask whether Pol IIo can
be co-immunoprecipitated with Sm snRNPs and/or SR pro-
teins. The results of the present study clearly show that Pol
II molecules containing a hyperphosphorylated CTD asso-
ciate with two classes of splicing factors, the Sm snRNPs
and non-snRNP SR proteins (Figs. 3 and 4). Significantly,
these associations resist exhaustive in vitro digestion with
RNase A (Fig. 5), and Pol IIo co-immunoprecipitates with
Sm snRNPs and SR proteins during mitosis, when tran-
scription is inactive (Fig. 6). Taken together, these results
indicate that transcriptionally unengaged, hyperphosphor-
ylated Pol II molecules are associated with Sm snRNPs
and certain SR proteins without the involvement of pre-
mRNA. Sm snRNPs and SR proteins may also be associ-
ated with transcriptionally engaged Pol IIo molecules, but
this hypothesis cannot be tested directly at the present
time since our reagents cannot distinguish transcription-
ally active from unengaged Pol II molecules. Interestingly,
a correlation between hyperphosphorylation of the CTD
and in vivo splicing was made previously in a study of
polytene nuclei in Drosophila, where a splicing factor was
localized only at chromosomal sites containing Pol IIo
(Weeks et al., 1993).
How can the results of the present study be reconciled
with the mounting evidence that the CTD has a transcrip-
tional function? First, the majority of studies indicating a
transcriptional role for the CTD have focused on early
steps of transcription; indeed, interactions involving the
CTD during elongation and after Pol II terminates tran-
scription have yet to be reported. Furthermore, with the
exception of the SR-like proteins described by Corden and
colleagues (Yuryev et al., 1996), all proteins reported to
interact with the CTD recognize this repetitive domain in
its unphosphorylated state (see Introduction). These re-
ported interactions are consistent with promoter clearance
models of CTD function, whereby unphosphorylated CTD
heptapeptides tether Pol II complexes to promoter-associ-
ated transcription factors at the pre-initiation stage of the
transcription cycle (see Introduction). But none of the re-
ported interactions involving the unphosphorylated CTD
preclude the possibility that the phosphorylated CTD may
mediate Pol II’s association with Sm snRNPs, SR proteins,
or other molecules. Similarly, our data indicating that hy-
perphosphorylated Pol II LS molecules associate with Sm
snRNPs and SR proteins do not contradict the possibility
Figure 6. Pol IIo is associated with splicing factors in nonchromosomal domains of mitotic cells. (A–D) Colocalization of Pol IIo and
SC35 in mitotic interchromatin granule clusters (MIGs). Mitotic MDCK cells were fixed with 1.75% paraformaldehyde, permeabilized
with 0.5% Triton X-100 and triple stained using anti-spliceosome assembly factor, mAb SC35 (A), anti-Pol IIo (B), and DNA-binding
dye, 49, 6-diamidino-2-phenylindole (DAPI) (C). Digital images were pseudocolored and merged using Registration v1.1d2R image
analysis software (see Materials and Methods). Arrows, mitotic interchromatin granule clusters (MIGs). Note that the SC35/Pol IIo en-
riched MIGs are clearly separate from the DAPI-stained prometaphase chromosomes. Another population of Pol IIo is distributed in a
stocking-like pattern which surrounds the individual chromosomes (B and D). Similar results were obtained using HeLa and many other
types of mammalian cells (Kim, E., L. Du, D.B. Bregman, and S.L. Warren, unpublished results). (E) Co-immunoprecipitation of Pol
IIo, Sm snRNPs, and SR family proteins from mitotic cell extracts. Pure mitotic HeLa cell extracts were prepared as described (see Ma-
terials and Methods). Immunoprecipitations were performed using the mAbs listed at top of panel: Y12 (anti-Sm snRNP), 3C5 and 104
(anti-SR family proteins), M2 (control IgG), and H22 (control IgM). Extract, HeLa cell mitotic extract. Immunoprecipitated material
was boiled in SDS sample buffer, electrophoresed, and immunoblotted with anti-Pol II mAb H14. Ig, mouse immunoglobulin m chains;
IIo, hyperphosphorylated form(s) of the largest subunit of RNA polymerase II. Numbers at margins of panels indicate apparent molec-
ular weights in kilodaltons.Kim et al. RNA Polymerase II and Splicing Factors 27
that the unphosphorylated CTD regulates early step(s) in
Pol II’s transcription cycle. Thus, after the CTD is phos-
phorylated, the promoter may “release” the polymerase
complex, which initiates RNA synthesis and becomes com-
petent to associate with Sm snRNPs and SR proteins (see
below).
Genetic analyses of CTD function in S. cerevisiae have
revealed no connections between the CTD and splicing
proteins (see Introduction of the following paper). Inacti-
vation of a temperature sensitive mutant CTD kinase
(KIN28) promptly shuts down RNA synthesis (Cismowski
et al., 1995), and partial truncation of Pol II’s CTD leads to
diminished transcription of specific genes (reviewed in
Young, 1991; Gerber et al., 1995). While both observations
strongly suggest a transcriptional role for the CTD, the
potential effects of CTD kinases or CTD truncations on
cotranscriptional pre-mRNA splicing would not manifest
themselves in the absence of pre-mRNA synthesis. Fi-
nally, mutant yeast SRB genes were genetically selected
for their ability to suppress CTD truncation mutants, and
in agreement with the CTD’s probable role in transcrip-
tional initiation, they encode proteins which associate with
basal transcription factors in the Pol II holoenzyme (for
review see Koleske and Young, 1995). But these results do
not contradict the possibility that the hyperphosphorylated
CTD interacts with splicing factors.
In summary, we have provided strong evidence indicat-
ing that Pol IIo associates with splicing factors of two
major families, the Sm snRNPs and the non-snRNP SR
proteins. The splicing factors associate with Pol IIo, appar-
ently without the direct involvement of pre-mRNA and at
times when the polymerase is not transcribing. Our obser-
vation that certain SR proteins can be co-immunoprecipi-
tated with mAb 8WG16, but not with mAbs H5 and H14,
suggests that Pol IIo’s association with SR proteins may
involve CTD phosphoepitopes. In agreement with the
data presented here, Pol IIo was recently shown to be
associated with active spliceosomes assembled on exoge-
nous RNA templates in vitro (Blencowe et al., 1996). The
present study, in conjunction with other recent studies
(Blencowe et al., 1996; Yuryev et al., 1996), suggests that a
phosphorylated form of the CTD may mediate Pol II’o as-
sociation with splicing factors. In an accompanying study,
we pursue this idea by asking whether CTD-derived pro-
teins affect splicing in vivo (Du and Warren, 1997). 
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